DE202016000774U1 - Magnesium, potassium, basic salts, melissa and B vitamins containing composition - Google Patents
Magnesium, potassium, basic salts, melissa and B vitamins containing composition Download PDFInfo
- Publication number
- DE202016000774U1 DE202016000774U1 DE202016000774.3U DE202016000774U DE202016000774U1 DE 202016000774 U1 DE202016000774 U1 DE 202016000774U1 DE 202016000774 U DE202016000774 U DE 202016000774U DE 202016000774 U1 DE202016000774 U1 DE 202016000774U1
- Authority
- DE
- Germany
- Prior art keywords
- range
- vitamin
- bis
- composition
- bereich von
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Molecular Biology (AREA)
Abstract
Eine Magnesium, mindestens ein basisch wirkendes Salz, Melisse und B-Vitamine B1, B2, B3, B6 und B12 enthaltende Zusammensetzung als Nahrungsergänzung bei stress- und ernährungsbedingten Mangel an Mikronährstoffen, Mineralstoffen und Sekundären Pflanzenstoffen, zur Reduktion von Stress, innerer Unruhe und Reizbarkeit, zu einer Verbesserung der Lebensqualität und Konzentrationsfähigkeit sowie zur Förderung des normalen, gesunden Blutdrucks und Herzrhythmus.A magnesium, at least one basic salt, lemon balm and B vitamins B1, B2, B3, B6 and B12 containing composition as a dietary supplement with stress and nutritional lack of micronutrients, minerals and phytochemicals, to reduce stress, anxiety and irritability to improve the quality of life and ability to concentrate and to promote normal, healthy blood pressure and heart rhythm.
Description
Die vorliegende Erfindung betrifft eine Magnesium, Kalium, basisch wirkende Salze, Melisse, und B-Vitamine enthaltende Zusammensetzung, die insbesondere zur Nahrungsergänzung bei stress- und ernährungsbedingten Mangel an Mikronährstoffen, Mineralstoffen und Pflanzenstoffen geeignet ist.The present invention relates to a magnesium, potassium, alkaline salts, lemon balm, and B vitamins containing composition which is particularly suitable for supplementation in stress and nutritional deficiency of micronutrients, minerals and phytochemicals.
Im Stand der Technik ist eine Verwendung von Vitaminpräparaten, Basenmittel, Melisse und Magnesium in separater Form bekannt. Allerdings müssten zur gleichen Wirkung verschiedenste Präparate kombiniert werden, um die gleichen synergistischen Effekte zu erhalten. Es ist daher die Aufgabe der vorliegenden Erfindung, ein Mittel zur Verfügung zu stellen, das durch synergistische Effekte in einem Mittel alle Wirkprinzipien vereint und den Nachteil des Standes der Technik überwindet.The prior art discloses a use of vitamin preparations, base agents, melissa and magnesium in separate form. However, for the same effect a variety of preparations would have to be combined in order to obtain the same synergistic effects. It is therefore the object of the present invention to provide a means that combines all the principles of action by synergistic effects in an agent and overcomes the disadvantage of the prior art.
Diese Aufgabe wird gelöst durch eine Magnesium, Kalium, basisch wirkende Salze, Melisse, und B-Vitamine enthaltende Zusammensetzung.This object is achieved by a magnesium, potassium, basic salts, melissa, and B vitamins-containing composition.
Überraschend konnte festgestellt werden, dass die erfindungsgemässe Zusammensetzung zur Reduktion von Stress, innerer Unruhe und Reizbarkeit, zu einer Verbesserung der Lebensqualität, zur Förderung des normalen, gesunden Blutdrucks und Herzrhythmus, vermehrten inneren Ruhe und Konzentrationsfähigkeit beitragen kann.Surprisingly, it has been found that the composition according to the invention can contribute to the reduction of stress, inner agitation and irritability, to an improvement in the quality of life, to the promotion of normal, healthy blood pressure and heart rhythm, increased inner peace and ability to concentrate.
Melisse wird verwendet als ”Extrakt” (Auszug von Melissenblättern), das insbesondere auf Hydroxyzimtsäure und Rosmarinsäure standardisiert ist, und/oder Melissenblattpulver.Melissa is used as an "extract" (extract of lemon balm leaves) which is in particular standardized to hydroxycinnamic acid and rosmarinic acid, and / or melissa leaf powder.
Kalium und Magnesium werden bevorzugt als Citrate verwendet, da Citrate eine hohe basische Wirkung auf den Stoffwechsel haben.Potassium and magnesium are preferably used as citrates, as citrates have a high basic effect on the metabolism.
Die Zusammensetzung umfasst vorzugsweise weiterhin wenigstens ein Vitamin oder Vitamingemisch ausgewählt aus der Gruppe umfassend Vitamin B1, Vitamin B2, B3, Vitamin B6, Vitamin B12, Folsäure, Pantothensäure und/oder Biotin; Vitamin C, Vitamin E und Vitamin A, Vitamin K1 und Vitamin D3 sowie den Mineralstoff Kalium.The composition preferably further comprises at least one vitamin or vitamin mixture selected from the group comprising vitamin B1, vitamin B2, B3, vitamin B6, vitamin B12, folic acid, pantothenic acid and / or biotin; Vitamin C, Vitamin E and Vitamin A, Vitamin K1 and Vitamin D3 as well as the mineral potassium.
In bevorzugten Ausführungsformen umfasst die Zusammensetzung, bezogen auf eine Tagesdosis der Zusammensetzung, als wirksame Bestandteile die Stoffe:
- – Vitamin B1 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Vitamin B2 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Nicotinamid im Bereich von >= 3 mg bis <= 60 mg, vorzugsweise im Bereich von >= 10 mg bis <= 30 mg, bevorzugt im Bereich von >= 12 mg bis <= 20 mg; und/oder
- – Vitamin B6 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Vitamin B12 im Bereich von >= 0,5 μg bis <= 1000 μg, vorzugsweise im Bereich von >= 1 μg bis <= 50 μg, bevorzugt im Bereich von >= 2 μg bis <= 5 μg; und/oder
- – Folsäure im Bereich von >= 50 μg bis <= 1 mg, vorzugsweise im Bereich von >= 100 μg bis <= 500 μg, bevorzugt im Bereich von >= 150 μg bis <= 300 μg; und/oder
- – Pantothensäure im Bereich von >= 2 mg bis <= 100 mg, vorzugsweise im Bereich von >= 4 mg bis <= 40 mg, bevorzugt im Bereich von >= 5 mg bis <= 10 mg; und/oder
- – Magnesium im Bereich von >= 20 mg bis <= 1000 mg, vorzugsweise im Bereich von >= 100 mg bis <= 600 mg, bevorzugt im Bereich von >= 300 mg bis <= 400 mg; und/oder
- – Citrate im Bereich von >= 20 mg bis <= 2000 mg, vorzugsweise im Bereich von 100 mg bis <= 1000 mg, bevorzugt im Bereich von 200 mg bis <= 500 mg
- – Melissenextrakt im von >= 5 mg bis <= 1000 mg, vorzugsweise im Bereich von 20 mg bis <= 700 mg, bevorzugt im Bereich von 150 mg bis <= 350 mg
- – Melissenblätter im von >= 5 mg bis <= 1000 mg, vorzugsweise im Bereich von 20 mg bis <= 700 mg, bevorzugt im Bereich von 150 mg bis <= 350 mg
- – Kalium im Bereich von >= 20 mg bis <= 1500 mg, vorzugsweise im Bereich von >= 300 mg bis <= 700 mg, bevorzugt im Bereich von >= 500 mg bis <= 800 mg; und/oder
- – Vitamin K1 im Bereich von >= 10 μg bis <= 120 μg, vorzugsweise im Bereich von >= 40 μg bis <= 100 μg, bevorzugt im Bereich von >= 50 μg bis <= 80 μg; und/oder
- – Vitamin D3 im Bereich von >= 1 μg bis <= 20 μg, vorzugsweise im Bereich von >= 2 μg bis <= 10 μg, bevorzugt im Bereich von >= 4 μg bis <= 7 μg; und/oder
- – Vitamin C im Bereich von >= 10 mg bis <= 1000 mg, vorzugsweise im Bereich von >= 20 mg bis <= 500 mg, bevorzugt im Bereich von >= 50 mg bis <= 100 mg; und/oder
- – Vitamin E im Bereich von >= 5 mg bis <= 100 mg, vorzugsweise im Bereich von >= 7 mg bis <= 50 mg, bevorzugt im Bereich von >= 9 mg bis <= 20 mg; und/oder
- – Biotin im Bereich von >= 20 μg bis <= 800 μg, vorzugsweise im Bereich von >= 30 μg bis <= 200 μg, bevorzugt im Bereich von >= 40 μg bis <= 80 μg; und/oder
- – Vitamin A im Bereich von >= 100 μg bis <= 1 mg, vorzugsweise im Bereich von >= 300 μg bis <= 900 μg, bevorzugt im Bereich von >= 650 μg bis <= 850 μg; und/oder
- - vitamin B1 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- Vitamin B2 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- Nicotinamide in the range of> = 3 mg to <= 60 mg, preferably in the range of> = 10 mg to <= 30 mg, preferably in the range of> = 12 mg to <= 20 mg; and or
- Vitamin B6 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- - Vitamin B12 in the range of> = 0.5 μg to <= 1000 μg, preferably in the range of> = 1 μg to <= 50 μg, preferably in the range of> = 2 μg to <= 5 μg; and or
- Folic acid in the range of> = 50 μg to <= 1 mg, preferably in the range of> = 100 μg to <= 500 μg, preferably in the range of> = 150 μg to <= 300 μg; and or
- Pantothenic acid in the range of> = 2 mg to <= 100 mg, preferably in the range of> = 4 mg to <= 40 mg, preferably in the range of> = 5 mg to <= 10 mg; and or
- Magnesium in the range of> = 20 mg to <= 1000 mg, preferably in the range of> = 100 mg to <= 600 mg, preferably in the range of> = 300 mg to <= 400 mg; and or
- Citrates in the range of> = 20 mg to <= 2000 mg, preferably in the range of 100 mg to <= 1000 mg, preferably in the range of 200 mg to <= 500 mg
- - Melissa extract in> = 5 mg to <= 1000 mg, preferably in the range of 20 mg to <= 700 mg, preferably in the range of 150 mg to <= 350 mg
- Melissa leaves in the range of> = 5 mg to <= 1000 mg, preferably in the range of 20 mg to <= 700 mg, preferably in the range of 150 mg to <= 350 mg
- Potassium in the range of> = 20 mg to <= 1500 mg, preferably in the range of> = 300 mg to <= 700 mg, preferably in the range of> = 500 mg to <= 800 mg; and or
- - Vitamin K1 in the range of> = 10 μg to <= 120 μg, preferably in the range of> = 40 μg to <= 100 μg, preferably in the range of> = 50 μg to <= 80 μg; and or
- - Vitamin D3 in the range of> = 1 μg to <= 20 μg, preferably in the range of> = 2 μg to <= 10 μg, preferably in the range of> = 4 μg to <= 7 μg; and or
- Vitamin C in the range of> = 10 mg to <= 1000 mg, preferably in the range of> = 20 mg to <= 500 mg, preferably in the range of> = 50 mg to <= 100 mg; and or
- Vitamin E in the range of> = 5 mg to <= 100 mg, preferably in the range of> = 7 mg to <= 50 mg, preferably in the range of> = 9 mg to <= 20 mg; and or
- - Biotin in the range of> = 20 μg to <= 800 μg, preferably in the range of> = 30 μg to <= 200 μg, preferably in the range of> = 40 μg to <= 80 μg; and or
- - Vitamin A in the range of> = 100 μg to <= 1 mg, preferably in the range of> = 300 μg to <= 900 μg, preferably in the range of> = 650 μg to <= 850 μg; and or
Die Zusammensetzung kann als Getränkepulver, Tablette, Kapseln, Granulat, Lösungen, Dispersionen und/oder Brausetabletten mit gleicher oder unterschiedlicher Zusammensetzung zur Anwendung kommen.The composition can be used as beverage powder, tablet, capsules, granules, solutions, dispersions and / or effervescent tablets of the same or different composition.
In besonders bevorzugten Ausführungsformen umfasst die Zusammensetzung, bezogen auf eine Tagesdosis der Zusammensetzung, als wirksame Bestandteile die Stoffe:
- – 360 mg Magnesium
- – 600 mg Kalium
- – 250 mg Melissenextrakt
- – 250 mg Melissenpulver
- – 80 mg Vitamin C;
- – 12 mg Vitamin E;
- – 1,1 mg Vitamin B1;
- – 1,4 mg Vitamin B2;
- – 16 mg Nicotinamid;
- – 1,4 mg Vitamin B6;
- – 2,5 μg Vitamin B12;
- – 75 μg Vitamin K1;
- – 5 μg Vitamin D3;
- – 200 μg Folsäure;
- – 6 mg Pantothensäure;
- – 50 μg Biotin;
- - 360 mg of magnesium
- - 600 mg of potassium
- - 250 mg lemon balm extract
- - 250 mg lemon balm powder
- - 80 mg of vitamin C;
- - 12 mg of vitamin E;
- - 1.1 mg of vitamin B1;
- - 1.4 mg of vitamin B2;
- - 16 mg nicotinamide;
- - 1.4 mg of vitamin B6;
- - 2.5 μg of vitamin B12;
- - 75 μg vitamin K1;
- - 5 μg vitamin D3;
- - 200 μg folic acid;
- - 6 mg pantothenic acid;
- - 50 μg biotin;
Nachfolgende Beispiele dienen zur Veranschaulichung der vorliegenden Erfindung: Beispiel 1: Tablette Beispiel 2: Getränkepulver The following examples serve to illustrate the present invention: Example 1: Tablet Example 2: Beverage powder
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202016000774.3U DE202016000774U1 (en) | 2016-02-07 | 2016-02-07 | Magnesium, potassium, basic salts, melissa and B vitamins containing composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202016000774.3U DE202016000774U1 (en) | 2016-02-07 | 2016-02-07 | Magnesium, potassium, basic salts, melissa and B vitamins containing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE202016000774U1 true DE202016000774U1 (en) | 2016-06-03 |
Family
ID=56233312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE202016000774.3U Active DE202016000774U1 (en) | 2016-02-07 | 2016-02-07 | Magnesium, potassium, basic salts, melissa and B vitamins containing composition |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE202016000774U1 (en) |
-
2016
- 2016-02-07 DE DE202016000774.3U patent/DE202016000774U1/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102011013224A1 (en) | Orthomolecular remedy for the effects of alcohol consumption | |
DE102006056454A1 (en) | Taste-free, granular nutritional supplement, useful e.g. for preventing osteoporosis and psoriasis, contains synergistic combination of Spirulina, Chlorella and Lithothamnium algae | |
DE202007013532U1 (en) | Composition containing phospholipids, suitable for strengthening the brain and memory function | |
AT513274B1 (en) | Dietary supplements | |
DE69936307T2 (en) | REDUCTION OF HOMOCYSTONE CONCENTRATION IN THE SERUM BY ALLIUM AND VITAMINS | |
DE102011008478A1 (en) | Integral dietary supplement with a physiological efficiency, useful for preventing e.g. prostate disorders, malnutrition, osteoporosis, cardiovascular disease, cancer, comprises dried broccoli, dried vegetables and/or dried fruits | |
DE2060601A1 (en) | Food supplements | |
EP3503865A1 (en) | Hair restorer preparation or food supplement | |
DE202009002126U1 (en) | Trace element-containing composition | |
DE202010001716U1 (en) | Melissa, magnesium, basic salts and B vitamins containing composition | |
DE202016000774U1 (en) | Magnesium, potassium, basic salts, melissa and B vitamins containing composition | |
WO2006108414A2 (en) | Agent for use in the therapy and prophylaxis of skin diseases | |
WO2020032832A2 (en) | Fortified drinking water | |
DE202004013660U1 (en) | Vitamin-containing product for nutritional supplementation, useful in cases of cardiovascular disease, also promotes bone formation | |
EP2545788A1 (en) | Dietary multi-component system | |
EP2508082B1 (en) | Food supplement preparation with amino acids and spice extract | |
DE202015102038U1 (en) | Caffeinated composition | |
DE202014008500U1 (en) | Composition containing Rhodiola rosea, Bacopa monnieri and pantothenic acid for mental performance. | |
DE4335441A1 (en) | Preventive medical composition for the human cardiovascular system | |
DE202006002700U1 (en) | Composition, useful as a food supplement, comprises olive leaf extract, pomegranate extract, red wine and/or grape extract and vitamin extract | |
DE202016105601U1 (en) | soft drink | |
DE102014118772A1 (en) | Administration form containing fungal components | |
DE10239161A1 (en) | Stimulating gastric function without causing undesirable side-effects, using nutritional supplement containing vitamin C and magnesium | |
EP1563743B1 (en) | Composition comprising a caffeine-containing substance, particularly guarana | |
CH713086B1 (en) | Food compositions, in particular food additives or food supplements. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification | ||
R150 | Utility model maintained after payment of first maintenance fee after three years | ||
R151 | Utility model maintained after payment of second maintenance fee after six years |